|Bid||0.00 x 1200|
|Ask||237.95 x 800|
|Day's Range||142.41 - 150.96|
|52 Week Range||130.96 - 293.20|
|Beta (5Y Monthly)||0.46|
|PE Ratio (TTM)||167.58|
|Earnings Date||May 02, 2022 - May 06, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||258.50|
If you want to know who really controls Penumbra, Inc. ( NYSE:PEN ), then you'll have to look at the makeup of its...
Penumbra Inc (NYSE: PEN) reported Q1 sales that beat Street expectations, driven by Vascular upside, and reiterated its 2022 revenue guidance. Wells Fargo lowered the price target to $265 from 321, which is equivalent to a 52.2% upside. At 9.5x (down from 12x as peer group valuation has been compressed) with a 2023 sales estimate of $1.02 billion, PEN shares would trade essentially in line with its peers, analysts write. Q1 revenue of $203.9 million (+21.8% ex-FX) beat the consensus of $195.04 m
Penumbra (PEN) delivered earnings and revenue surprises of -116.67% and 4.03%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?